IPNV VP2-VP3 fusion gene was cloned into a pET-26b expression vector and recombinant protein was produced in E. coli host.
E. coli-expressed IPNV VP2-VP3 fusion protein (vaccine) was intraperitoneally administered to rainbow trout.
The recombinant IPNV vaccine induced strong immune responses and protected vaccinated fish against IPNV challenge.
The relative percent survival rate (RPS) of survivors was 83% for the vaccinated group.
E. coli-expressed IPNV vaccine significantly reduced virus load in tissues of the vaccinated fish.